We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer.
- Authors
Schneeweiss, Andreas; Park-Simon, Tjoung-Won; Albanell, Joan; Lassen, Ulrik; Cortés, Javier; Dieras, Veronique; May, Marcus; Schindler, Christoph; Marmé, Frederik; Cejalvo, Juan Miguel; Martinez-Garcia, Maria; Gonzalez, Iria; Lopez-Martin, Jose; Welt, Anja; Levy, Christelle; Joly, Florence; Michielin, Francesca; Jacob, Wolfgang; Adessi, Céline; Moisan, Annie
- Publication
Investigational New Drugs, 2018, Vol 36, Issue 5, p848
- ISSN
0167-6997
- Publication type
Article
- DOI
10.1007/s10637-018-0562-4